| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.056 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.051 | 0.8 |